LENLOVIQ
Live / Applied — Suspended — suspension letter mailed (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 14 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99595049
- Mark type
- Stylized text
- Filed
- 14 Jan 2026
- Attorney of record
- Shelley Lai
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention of HIV infection; Pharmaceutical preparations for the treatment and prevention of HIV infection
Owner
- Gilead Sciences Ireland UC, Carrigtohill, Co. Cork, IE
Prosecution history
- 26 Feb 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 26 Feb 2026 — LETTER OF SUSPENSION E-MAILED
- 26 Feb 2026 — SUSPENSION LETTER WRITTEN
- 25 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Feb 2026 — NON-FINAL ACTION E-MAILED
- 20 Feb 2026 — NON-FINAL ACTION WRITTEN
- 19 Feb 2026 — ASSIGNED TO EXAMINER
- 14 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 14 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Jan 2026 — NEW APPLICATION ENTERED